PodPitch
PodcastsRank #2387
Artwork for Business Of Biotech

Business Of Biotech

Matt Pillar
Share:
ManagementPodcastsBusinessScienceLife SciencesENunited-statesDaily or near-daily
4.7 / 5
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.
Top 4.8% by pitch volume (Rank #2387 of 50,000)Data updated Feb 10, 2026

Key Facts

Publishes
Daily or near-daily
Episodes
292
Founded
N/A
Category
Management
Number of listeners
Private
Hidden on public pages

Listen to this Podcast

AppleSpotify
EpisodesMetricsListenersContactsSimilarFAQs
PreviousSpace Business PodcastRank #2386NextMachine Learning Street Talk (MLST)Rank #2388
Pitch this podcast
Get the guest pitch kit.
Book a quick demo to unlock the outreach details you actually need before you hit send.
  • Verified contact + outreach fields
  • Exact listener estimates (not just bands)
  • Reply rate + response timing signals
10 minutes. Friendly walkthrough. No pressure.
Book a demo
Public snapshot
Audience: 8K–20K / month
Canonical: https://podpitch.com/podcasts/business-of-biotech
Cadence: Active weekly
Reply rate: 5–10%

Latest Episodes

Back to top

BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

Mon Feb 02 2026

Listen

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim, returns to the show during the J.P. Morgan Healthcare Conference, and following his departure from LEO Pharma (see episode 164). Brian talks about new opportunities in obesity, the benefits of private ownership in funding early science, Boehringer's deal strategy, using AI to improve commercialization efforts, and the FDA's selection of zongertinib (in patients with HER2-mutant NSCLC) for the Commissioner's National Priority Voucher program.     Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

More

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim, returns to the show during the J.P. Morgan Healthcare Conference, and following his departure from LEO Pharma (see episode 164). Brian talks about new opportunities in obesity, the benefits of private ownership in funding early science, Boehringer's deal strategy, using AI to improve commercialization efforts, and the FDA's selection of zongertinib (in patients with HER2-mutant NSCLC) for the Commissioner's National Priority Voucher program.     Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

Key Metrics

Back to top
Pitches sent
67
From PodPitch users
Rank
#2387
Top 4.8% by pitch volume (Rank #2387 of 50,000)
Average rating
4.7
Ratings count may be unavailable
Reviews
14
Written reviews (when available)
Publish cadence
Daily or near-daily
Active weekly
Episode count
292
Data updated
Feb 10, 2026
Social followers
3.2K

Public Snapshot

Back to top
ManagementPodcastsBusinessScienceLife Sciences
Country
United States
Language
English
Language (ISO)
Release cadence
Daily or near-daily
Latest episode date
Mon Feb 02 2026

Audience & Outreach (Public)

Back to top
Audience range
8K–20K / month
Public band
Reply rate band
5–10%
Public band
Response time band
30+ days
Public band
Replies received
6–20
Public band

Public ranges are rounded for privacy. Unlock the full report for exact values.

Presence & Signals

Back to top
Social followers
3.2K
Contact available
Yes
Masked on public pages
Sponsors detected
Private
Hidden on public pages
Guest format
Private
Hidden on public pages

Social links

No public profiles listed.

Demo to Unlock Full Outreach Intelligence

We publicly share enough context for discovery. For actionable outreach data, unlock the private blocks below.

Audience & Growth
Demo to unlock
Monthly listeners49,360
Reply rate18.2%
Avg response4.1 days
See audience size and growth. Demo to unlock.
Contact preview
j***@hidden
Get verified host contact details. Demo to unlock.
Sponsor signals
Demo to unlock
Sponsor mentionsLikely
Ad-read historyAvailable
View sponsorship signals and ad read history. Demo to unlock.
Book a demo

How To Pitch Business Of Biotech

Back to top

Want to get booked on podcasts like this?

Become the guest your future customers already trust.

PodPitch helps you find shows, draft personalized pitches, and hit send faster. We share enough public context for discovery; for actionable outreach data, unlock the private blocks.

  • Identify shows that match your audience and offer.
  • Write pitches in your voice (nothing sends without you).
  • Move from “maybe later” to booked interviews faster.
  • Unlock deeper outreach intelligence with a quick demo.

This show is Rank #2387 by pitch volume, with 67 pitches sent by PodPitch users.

Book a demoBrowse more shows10 minutes. Friendly walkthrough. No pressure.

Reviews

Back to top
4.7 / 5
RatingsN/A
Written reviews14

We summarize public review counts here; full review text aggregation is not shown on PodPitch yet.

Frequently Asked Questions About Business Of Biotech

Back to top

What is Business Of Biotech about?

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.

How often does Business Of Biotech publish new episodes?

Daily or near-daily

How many listeners does Business Of Biotech get?

PodPitch shows a public audience band (like "8K–20K / month"). Book a demo to unlock exact audience estimates and how we calculate them.

How can I pitch Business Of Biotech?

Use PodPitch to access verified outreach details and pitch recommendations for Business Of Biotech. Start at https://podpitch.com/try/1.

Which podcasts are similar to Business Of Biotech?

This page includes internal links to similar podcasts. You can also browse the full directory at https://podpitch.com/podcasts.

How do I contact Business Of Biotech?

Public pages only show a masked contact preview. Book a demo to unlock verified email and outreach fields.

Quick favor for your future self: want podcast bookings without the extra mental load? PodPitch helps you find shows, draft personalized pitches, and hit send faster.

Book a demoBrowse more shows